BioVie shareholders elected all six director nominees at the company’s Nov. 10 annual meeting, ratified its accounting firm and approved a major expansion of its equity incentive plan. The plan’s share pool available for awards rises from 399,509 to 3.1 million shares.
- Equity plan: Shareholders approved increasing the number of shares available for awards by about 2.7 million. The new 3.1 million-share pool is roughly 7.8 times the former amount and equals about 36% of BioVie’s 8.68 million shares outstanding on the Sept. 21 record date.
- Vote on the plan: The measure received 1,020,704 votes in favor, 689,489 against and 136,939 abstentions. A further 2,902,235 shares were recorded as broker non-votes.
- Directors: Amy Chappell, Cuong Do, Kameel Farag, James Lang, Sigmund Rogich and Michael Sherman were each elected to serve until the next annual meeting. Each received between about 1.72 million and 1.73 million votes in favor; withhold votes ranged from about 115,000 to 127,000.
- Auditor: Shareholders ratified EisnerAmper LLP as BioVie’s independent accounting firm for the fiscal year ending June 30, 2027. The vote was 4,411,653 for, 274,205 against and 63,509 abstentions.
- Meeting participation: Holders of 4,749,367 shares were present or represented by proxy, enough to establish a quorum.
The plan approval expands the amount of stock BioVie can make available through future equity awards; it does not mean those shares have already been issued. If awards are granted and shares issued, they could increase the company’s share count and dilute existing holders.
